{
  "ticker": "SION",
  "company_name": "Sionna Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07035990",
      "title": "Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Cystic Fibrosis (CF)",
      "start_date": "2025-07-23",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "Sionna Therapeutics Inc."
    },
    {
      "nct_id": "NCT07108153",
      "title": "Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Cystic Fibrosis (CF)",
      "start_date": "2025-11-03",
      "completion_date": "2026-07",
      "enrollment": 0,
      "sponsor": "Sionna Therapeutics Inc."
    }
  ],
  "summary": {
    "total_trials": 2,
    "by_phase": {
      "PHASE1": 1,
      "PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 2
    },
    "active_trials": 2,
    "completed_trials": 0,
    "conditions": [
      "Cystic Fibrosis (CF)"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:52.584547",
    "search_query": "Sionna Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Sionna+Therapeutics,+Inc."
  }
}